中 / EN
2026-07-29 00:00 Industry News Source language EN

Science Corporation Appoints Nevada Sanchez to Lead Engineering

Summary Science has appointed Nevada Sanchez as Executive Vice President of Engineering to lead its engineering organizations. According to the company, Sanchez co-founded Butterfly Network and served as Senior Vice President and Chief Innovation Officer, with experience taking medical imaging technology from prototype to product deployment. The appointment comes as Science begins the European commercial launch of PRIMA, its brain-computer interface retinal implant. The company also says it is accelerating its Biohybrid neural interface and Vessel perfusion programs while expanding Science Foundry's microelectromechanical systems fabrication capabilities.
Why it matters The role spans multiple engineering organizations rather than a single product. Science links Sanchez's experience in medical imaging development and engineering team building to its expanding neural interface and fabrication activities.

Science任命Nevada Sanchez为工程执行副总裁
Image: Science

BCIwiki (bciwiki.com) — In an announcement dated July 29, 2026, Science Corporation appointed Nevada Sanchez as Executive Vice President of Engineering to lead its engineering organizations. The announcement said the company was beginning the European commercial launch of its PRIMA retinal implant while expanding neural interface development and fabrication activities.

According to Science, Sanchez co-founded Butterfly Network in 2011 and until recently served as its Senior Vice President and Chief Innovation Officer. During his tenure, he conceived and led the development of an ultrasound system on a chip and built the engineering organization that took the technology from a prototype to a globally deployed platform. Science cited these experiences as the basis for his engineering leadership credentials.

Science also said it is accelerating development of its Biohybrid neural interface and Vessel perfusion programs while expanding Science Foundry and its microelectromechanical systems (MEMS) fabrication capabilities. The company views Sanchez's cross-disciplinary engineering leadership as support for these activities. The product launch and development updates are company statements, not new clinical efficacy results.

Compiled by BCIwiki from public sources

Sources · 4
science.xyz 2026-07-29
science.xyz 2026-07-29
science.xyz 2026-07-29
science.xyz 2026-07-29
Read original ↗
Suggest a correction Revisions · none 中 / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About